Who is Ireland’s most scalable start-up

The FutureScope One2Watch competition seeks to find Ireland’s most scalable business idea and awards the winning company with a platform to support its growth.

 

0 +

APPLICANTS

0

FINALISTS

0

PITCHES

0 1

WINNER

FutureScope One2Watch

The FutureScope One2Watch competition is open to entrepreneurs and start-ups from any sector whose business is beyond the concept stage, is revenue generating, is under four years since incorporation and has clear potential to scale.

The brightest and most innovative start-ups and entrepreneurs in the country will compete for the opportunity to present their business idea on the FutureScope stage were 1,000 of those most involved in Ireland’s tech and start-up ecosystem converge to explore business and collaboration opportunities arising from emerging technologies.

The winner will present with the biggest market opportunity and the most capable team to realise it. Entry to the competition is open to entrepreneurs and start-ups from any sector whose idea is beyond the concept stage and is under five years since incorporation.

The One2Watch competition for 2022 will open shortly.   To find out more please email info@futurescope.ie

Application process will open shortly

The One2Watch competition for 2022 will open shortly.   To find out more please email info@futurescope.ie

Criteria

Entry to the competition is open to entrepreneurs and start-ups from any sector whose business is beyond the concept stage, is revenue generating, is under four years since incorporation and has clear potential to scale.

Full criteria can be found on the application form, once published. If you’re a start-up with a scalable business idea, you could be the FutureScope One2Watch 2022 and win:

testimonial-author two
Conor Harkin Chief Science Officer and Co-founder, ProVerum Medical - Winner 2017

Winning One2Watch provided excellent validation and great exposure for ProVerum medical. Since winning the competition ProVerum Medical who provide a minimally invasive treatment for benign prostatic hyperplasia (BPH) have secured an investment that will allow human trials to be conducted in late 2018.

Lizzy Hayashida, Co-founder, Change Donations and Winner of 2019's One2Watch Competition

Winning FutureScope's One2Watch competition was an incredibly valuable experience and was the catalyst for our successes thereafter. The mentorship, counsel, and advice provided by the Dublin BIC were instrumental in our growth, and we are eternally grateful for all of the help and support we have received.

Ronan Kelly Founder, Bespoke Choice - Winner 2018

We’re absolutely thrilled to win the One2Watch competition, especially in a year with such strong competition. It’s a very exciting time in the Bespoke Choice journey, as we have just launched our service this week and are seeing a number of high-profile customers already signing up.